[1]
M B, K., J Sh, G. and E E, L. 2018. COST-EFFECTIVENESS OF HLA-B*5701 PROSPECTIVE GENETIC SCREENING OF HYPERSENSITIVITY TO ABACAVIR. Asian Journal of Pharmaceutical and Clinical Research. 11, 2 (Feb. 2018), 281–283. DOI:https://doi.org/10.22159/ajpcr.2018.v11i2.22519.